In SPMS patients, a significant positive correlation was observed between SEMA3A and neurofilament levels (r = 0.359; p = 0.007), whereas no such correlation was present in RRMS (r = 0.191; p = 0.137). This evidence concerns the gene SEMA3A and secondary progressive multiple sclerosis.